Grants per year
Personal profile
Research Interests
Dr Chaudhury is a pediatric stem sell transplanter with special interest in transplantation strategies to reduce toxicities, stem cell transplants for non-malignant disorders utilizing reduced intensity transplants, immunologic mechanisms of graft failure and graft versus host disease (GVHD) following stem cell transplantation (SCT) and pediatric Chronic Myeloid Leukemia. These efforts are directed at making transplant safer, better tolerated and more accessible by reducing associated toxicities and improving outcomes.
Clinical research leadership in designing and implementing trials to improve outcomes in stem cell transplant.
Chronic Myeloid Leukemia, Transplantation of hematological non-malignant disorders, chronic myeloid leukemia and use of cellular-immunotherapy in malignancies.
Certifications and Licenses
| Pediatrics | |
| Pediatric Hematology-Oncology |
Training Experience
| 1998 | Residency, B J Medical College, India |
| 2000 | Internship, Bellevue Hospital/NYU Medical Center |
| 2003 | Residency, New York Presb. Hospital |
| 2006 | Fellowship, New York Hospital/Cornell Medical Center |
| 2007 | Fellowship, Memorial Sloan-Kettering Cancer Center |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Pediatrics, University of Poona
… → 1998
MBBS, Ophthalmology, University of Poona
… → 1994
Research interests keywords
- Clinical Research
- Hematology
- Oncology
- Regenerative Medicine
- Stem Cells
- Transplantation
Fingerprint
Dive into the research topics where Sonali Chaudhury is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phase 1/2 Dose Finding, Safety and Efficacy Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)
Chaudhury, S. (PD/PI)
3/4/19 → 8/31/50
Project: Research project
-
Practice patterns and incidence of adenovirus infections in hematopoietic cell transplant in the United States: AdVance US
Chaudhury, S. (PD/PI)
8/5/18 → 8/31/50
Project: Research project
-
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity
Bognàr, T., Garcia-Rosa, M., Lalmohamed, A., Güngör, T., Hauri-Hohl, M., Prockop, S., Oram, L., Pai, S. Y., Brooks, J., Savic, R. M., Dvorak, C. C., Long-Boyle, J. R., Krajinovic, M., Bittencourt, H., Teyssier, A. C., Théoret, Y., Martinez, C., Egberts, T. C. G., Morales, E. & Slatter, M. & 18 others, , Oct 8 2024, In: Blood Advances. 8, 19, p. 5137-5145 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial
Eapen, M., Kou, J., Andreansky, M., Bhatia, M., Brochstein, J., Chaudhury, S., Haight, A. E., Haines, H., Jacobsohn, D., Jaroscak, J., Kasow, K. A., Krishnamurti, L., Levine, J. E., Leung, K., Margolis, D., Yu, L. C., Horowitz, M. M., Kamani, N., Walters, M. C. & Shenoy, S., Apr 2024, In: American Journal of Hematology. 99, 4, p. 785-788 4 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
Verma, A., Chi, Y. Y., Malvar, J., Lamble, A., Chaudhury, S., Agarwal, A., Li, H. T., Liang, G., Leong, R., Brown, P. A., Kaplan, J., Schafer, E. S., Slone, T., Pauly, M., Chang, B. H., Stieglitz, E., Wayne, A. S., Hijiya, N. & Bhojwani, D., Feb 2024, In: Cancers. 16, 3, 496.Research output: Contribution to journal › Article › peer-review
Open Access -
Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study
Eissa, H., Thakar, M. S., Shah, A. J., Logan, B. R., Griffith, L. M., Dong, H., Parrott, R. E., O'Reilly, R. J., Dara, J., Kapoor, N., Forbes Satter, L., Chandra, S., Kapadia, M., Chandrakasan, S., Knutsen, A., Jyonouchi, S. C., Molinari, L., Rayes, A., Ebens, C. L. & Teira, P. & 38 others, , Jan 2024, In: Journal of Allergy and Clinical Immunology. 153, 1, p. 287-296 10 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia
Abraham, R. S., Basu, A., Heimall, J. R., Dunn, E., Yip, A., Kapadia, M., Kapoor, N., Satter, L. F., Buckley, R., O'Reilly, R., Cuvelier, G. D. E., Chandra, S., Bednarski, J., Chaudhury, S., Moore, T. B., Haines, H., Dávila Saldaña, B. J., Chellapandian, D., Rayes, A. & Chen, K. & 37 others, , Apr 2024, In: Clinical Immunology. 261, 109942.Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Datasets
-
Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML
Smith, S. M. (Creator), Zhang, S. (Creator), Sundaram, V. (Creator), Roth, M. (Creator), Andolina, J. R. (Creator), Schapira, L. (Creator), Sakamoto, K. M. (Creator), Kolb, E. A. (Creator), Hijiya, N. (Creator) & Chaudhury, S. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17263667.v1, https://tandf.figshare.com/articles/online_resource/Physician_risk_perceptions_and_surveillance_practices_for_tyrosine_kinase_inhibitor_long-term_effects_in_pediatric_CML/17263667/1
Dataset